TheraRadar

Pharma Intelligence, Simplified

Landscape Cardiovascular

Hypertension

1,045 clinical trials

305 active
/
1045 total (since 2015)
67
Phase 1 Active
248 total
103
Phase 2 Active
336 total
91
Phase 3 Active
297 total
77
Phase 4 Active
244 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
Boryung Pharmaceutical Co., Ltd 6 31 0
Addpharma Inc. 5 10 0
Merck 5 5 0
Actelion 4 13 8
Insmed Incorporated 4 2 1
Eli Lilly 4 0 1
Liquidia Technologies, Inc. 3 1 1
Tenax Therapeutics, Inc. 3 1 0
SpyGlass Pharma, Inc. 3 0 0
Chong Kun Dang Pharmaceutical 2 21 0
United Therapeutics 2 5 14
Novartis 2 4 5
AbbVie 2 5 0
Glaukos Corporation 2 3 0
35Pharma Inc 2 0 2
NCT07064473 RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Boehringer Ingelheim n=11,800
NCT07179380 RECRUITING
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Insmed Incorporated n=344
NCT06948435 RECRUITING
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
Eli Lilly and Company n=487
NCT06948422 RECRUITING
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
Eli Lilly and Company n=974
NCT06952530 RECRUITING
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
Eli Lilly and Company n=487
NCT07436689 ENROLLING BY INVITATION
Long-Term Open-Label Extension Study of Oral Levosimendan
Tenax Therapeutics, Inc. n=800
NCT07218029 RECRUITING
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
Merck Sharp & Dohme LLC n=815
NCT04175600 ACTIVE NOT RECRUITING
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
Actelion n=138
NCT05649748 ACTIVE NOT RECRUITING
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)
Insmed Incorporated n=91
NCT05649722 ACTIVE NOT RECRUITING
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Insmed Incorporated n=31
NCT03683186 ENROLLING BY INVITATION
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
United Therapeutics n=1,000
NCT07181109 RECRUITING
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Alnylam Pharmaceuticals n=11,000
NCT05983250 RECRUITING
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Tenax Therapeutics, Inc. n=230
NCT05968430 ACTIVE NOT RECRUITING
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
Mineralys Therapeutics Inc. n=1,076
NCT04273945 ACTIVE NOT RECRUITING
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
Actelion n=935
NCT05179876 RECRUITING
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
Actelion n=280
NCT02562235 ACTIVE NOT RECRUITING
Riociguat in Children With Pulmonary Arterial Hypertension (PAH)
Bayer n=24
NCT06274801 ACTIVE NOT RECRUITING
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
GB002, Inc. n=316
NCT05551104 RECRUITING
Safest Choice of Antihypertensive Regimen for Postpartum Hypertension
Loma Linda University n=500
NCT07365332 NOT YET RECRUITING
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Inhibikase Therapeutics n=486
NCT07181382 RECRUITING
Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
GB002, Inc. n=480
NCT07354516 NOT YET RECRUITING
Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension
Qlaris Bio, Inc. n=36
NCT07335211 RECRUITING
Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Huons Co., Ltd. n=206
NCT07082816 ACTIVE NOT RECRUITING
Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction
Alcon Research n=489
NCT05844462 RECRUITING
Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Assistance Publique - Hôpitaux de Paris n=200
NCT07223502 RECRUITING
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease
Sarfez Pharmaceuticals, Inc. n=30
NCT06671392 ACTIVE NOT RECRUITING
A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension
Daewoong Pharmaceutical Co. LTD. n=192
NCT06344104 ACTIVE NOT RECRUITING
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
AstraZeneca n=326
NCT06804161 RECRUITING
SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension
Prof. Dr. med. Ingo Eitel n=3,000
NCT07288398 RECRUITING
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Tenax Therapeutics, Inc. n=540
NCT07285655 NOT YET RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Liquidia Technologies, Inc. n=344
NCT04691154 ACTIVE NOT RECRUITING
A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD
Liquidia Technologies, Inc. n=28
NCT06643819 RECRUITING
Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A
Chong Kun Dang Pharmaceutical n=324
NCT05732727 RECRUITING
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
University Hospital, Tours n=720
NCT07245680 NOT YET RECRUITING
COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities
Assistance Publique - Hôpitaux de Paris n=186
NCT07030101 NOT YET RECRUITING
A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension
EMS n=400
NCT07232966 NOT YET RECRUITING
Perirenal Adipose Tissue Modification Therapy for Resistant Hypertension
Yan Li n=220
NCT07234032 NOT YET RECRUITING
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Insmed Incorporated n=344
NCT07231900 NOT YET RECRUITING
Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients
Assaf-Harofeh Medical Center n=40
NCT07222852 NOT YET RECRUITING
Cardiovascular Protection After Preeclampsia With Enalapril
Women and Infants Hospital of Rhode Island n=60
NCT04298034 ACTIVE NOT RECRUITING
Preeclampsia Postpartum Antihypertensive Treatment
Medical College of Wisconsin n=300
NCT07218783 RECRUITING
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
SpyGlass Pharma, Inc. n=400
NCT07218796 RECRUITING
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
SpyGlass Pharma, Inc. n=400
NCT04967989 RECRUITING
Clarifying the Optimal Application of SLT Therapy Trial
University of Pittsburgh n=790
NCT07187206 RECRUITING
Safety and Efficacy of FETO in CDH Phase III
Children's Hospital Medical Center, Cincinnati n=75
NCT07083765 RECRUITING
Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
Ablative Solutions, Inc. n=142
NCT06647745 RECRUITING
A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension
THPharm Corp. n=221
NCT05473520 RECRUITING
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
National University Hospital, Singapore n=150
NCT06643130 RECRUITING
Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
JW Pharmaceutical n=162
NCT04356326 RECRUITING
Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy
Centre Hospitalier Intercommunal Creteil n=500
NCT03891446 ACTIVE NOT RECRUITING
Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
AbbVie n=455
NCT07080229 RECRUITING
Intranasal Dexmedetomidine on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery
Suez Canal University n=126
NCT05852054 ACTIVE NOT RECRUITING
Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)
Northwestern University n=1,500
NCT06150560 RECRUITING
A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
Mayo Clinic n=120
NCT06174766 RECRUITING
A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients
Hanmi Pharmaceutical Company Limited n=324
NCT07008365 RECRUITING
The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure
Instituto de Investigación Sanitaria Aragón n=168
NCT06263816 NOT YET RECRUITING
Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial
University Hospital, Tours n=290
NCT06350032 RECRUITING
Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
AOP Orphan Pharmaceuticals AG n=20
NCT04007289 ACTIVE NOT RECRUITING
Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension
Assistance Publique - Hôpitaux de Paris n=166
NCT06646354 ENROLLING BY INVITATION
To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia
Hyundai Pharm n=125
NCT06922240 RECRUITING
Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)
Suqiao Yang n=68
NCT04971720 RECRUITING
PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
University of Alabama at Birmingham n=160
NCT06941441 RECRUITING
PAH Exercise Study
University of Washington n=10
NCT06863987 ENROLLING BY INVITATION
A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents
Shandong New Time Pharmaceutical Co., LTD n=342
NCT06852079 RECRUITING
Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan
Abdul Bari n=119
NCT06666855 RECRUITING
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
Santen Pharmaceutical Co., Ltd. n=338
NCT04062565 RECRUITING
Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
University of Arizona n=20
NCT05460416 RECRUITING
Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer
Centre Hospitalier Universitaire de Liege n=276
NCT05470205 RECRUITING
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Thomas Jefferson University n=660
NCT06291207 RECRUITING
A Study to Evaluate the Efficacy and Safety of AD-224
Addpharma Inc. n=252
NCT06441630 RECRUITING
A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B
Addpharma Inc. n=251
NCT03992755 ACTIVE NOT RECRUITING
Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil
Liquidia Technologies, Inc. n=92
NCT06771245 NOT YET RECRUITING
A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. n=606
NCT06716970 NOT YET RECRUITING
QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension
Wuhan Createrna Science and Technology Co., Ltd n=810
NCT06608472 NOT YET RECRUITING
Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension
Eurofarma Laboratorios S.A. n=292
NCT06696248 NOT YET RECRUITING
Carvedilol and Alverine in Portal Hypertension
Shanghai Changzheng Hospital n=30
NCT06683040 RECRUITING
Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation n=260
NCT05636826 RECRUITING
Olive Leaf Extracts in the Control of Hypertension
University of Monastir n=500
NCT05824923 RECRUITING
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure
Pulnovo Medical (Wuxi) Co., Ltd. n=264
NCT06473493 NOT YET RECRUITING
The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal Hypertension
Shanghai Changzheng Hospital n=30
NCT06470386 NOT YET RECRUITING
The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis
Shanghai Changzheng Hospital n=178
NCT06452498 NOT YET RECRUITING
Preeclampsia Intervention Netherlands
Amsterdam UMC n=180
NCT06434753 RECRUITING
Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.
Hospital Universitari Vall d'Hebron Research Institute n=300
NCT06061718 ACTIVE NOT RECRUITING
Travoprost Intraocular Implant in Conjunction With Cataract Surgery
Glaukos Corporation n=60
NCT06220773 RECRUITING
A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy
Boryung Pharmaceutical Co., Ltd n=276
NCT06416865 RECRUITING
Efficacy and Safety of AJU-C52 in Essential Hypertension Patients
AJU Pharm Co., Ltd. n=190
NCT06348576 RECRUITING
Phase III Study to Evaluate the Efficacy and Safety of AD-209
Addpharma Inc. n=280
NCT06361823 NOT YET RECRUITING
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
Capital Medical University n=74
NCT06209710 ENROLLING BY INVITATION
Balloon Pulmonary Angioplasty vs. Combined Approach With Pulmonary Artery Denervation in CTEPH: Effectiveness Comparison
Boris Dzudovic n=20
NCT02910414 ACTIVE NOT RECRUITING
TARGET BP I Clinical Trial
Ablative Solutions, Inc. n=300
NCT05401357 RECRUITING
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Amneal Pharmaceuticals, LLC n=168
NCT07448506 COMPLETED
PHASE III, RANDOMIZED, ACTIVE-COMPARATOR CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF NIFEDIPINE 30MG EXTENDED-RELEASE IN ADULT PATIENTS DIAGNOSED WITH MILD OR MODERATE HYPERTENSION IN COLOMBIA.
Laboratorios Richmond S.A.C.I.F. n=50
NCT05818137 COMPLETED
A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020)
Merck Sharp & Dohme LLC n=46
NCT04896008 COMPLETED
A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA n=173
NCT05934526 COMPLETED
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
GB002, Inc. n=390
NCT03626688 COMPLETED
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
United Therapeutics n=728
NCT04039464 COMPLETED
Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension
Johns Hopkins University n=28
NCT02932410 COMPLETED
A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)
Actelion n=165
NCT06682000 COMPLETED
Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension
Daewoong Pharmaceutical Co. LTD. n=192
NCT06168409 COMPLETED
A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension
AstraZeneca n=218
NCT07385040 COMPLETED
Comparison of IV Lignocain and IV Dexmedetomidine for Attenuation of Laryngoscopic Stress Response to Direct Laryngoscopy
Shaheed Mohtarma Benazir Bhutto Institue of Trauma n=62
NCT06236061 COMPLETED
Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy
Novartis Pharmaceuticals n=718
NCT05301634 COMPLETED
Comparison Between Bilateral Infraorbital Block Versus Intranasal Bupivacaine in Transsphenoidal Pituitary Adenoma Resection
Cairo University n=60
NCT03944512 TERMINATED
Pravastatin to Prevent Preeclampsia
The George Washington University Biostatistics Center n=102
NCT03904693 COMPLETED
Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
Actelion n=187
NCT03794583 TERMINATED
Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
United Therapeutics n=41
NCT06153693 COMPLETED
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension
Mineralys Therapeutics Inc. n=1,083
NCT07251920 COMPLETED
Isometric Resistance Training and Dose-dependent Effects in Pre- and Hypertensive Adults
The University of Northampton n=30
NCT06165250 COMPLETED
A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C
Boryung Pharmaceutical Co., Ltd n=156
NCT06034743 COMPLETED
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
AstraZeneca n=796
NCT05167825 COMPLETED
A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension
Janssen Pharmaceutical K.K. n=7
NCT02699645 COMPLETED
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial
The George Institute n=1,671
NCT05385770 COMPLETED
Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects
Celltrion n=890
NCT03508739 SUSPENDED
Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition
University of Pennsylvania n=25
NCT05794555 COMPLETED
LiveSMART Trial to Prevent Falls in Patients With Cirrhosis
University of Michigan n=230
NCT04630808 COMPLETED
MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Nicox Ophthalmics, Inc. n=696
NCT03850782 COMPLETED
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
AbbVie n=515
NCT07116863 COMPLETED
A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential Hypertension
Kyungdong Pharmaceutical Co., Ltd. n=286
NCT04780932 COMPLETED
Initial Dual Oral Combination Therapy Versus Standard-of-care Initial Oral Monotherapy Prior to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Assistance Publique - Hôpitaux de Paris n=96
NCT06685679 COMPLETED
Melatonin for Pulmonary Hypertension in Full Term Neonates
Ain Shams University n=40
NCT05920005 COMPLETED
Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension
Hospital Israelita Albert Einstein n=702
NCT03187678 COMPLETED
Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial Hypertension
Actelion n=20
NCT04271475 TERMINATED
A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
Actelion n=127
NCT04445519 COMPLETED
Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Nicox Ophthalmics, Inc. n=691
NCT03068130 TERMINATED
Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER
Biogen n=261
NCT05288400 COMPLETED
Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension.
Servier n=150
NCT02657356 TERMINATED
Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
Biogen n=202
NCT04518306 COMPLETED
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
George Medicines PTY Limited n=755
NCT04518293 COMPLETED
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
George Medicines PTY Limited n=1,385
NCT04732221 COMPLETED
A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)
Merck Sharp & Dohme LLC n=168
NCT06000748 TERMINATED
NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients
University of California, San Francisco n=6
NCT04811092 COMPLETED
Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13)
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA n=321
NCT04565990 COMPLETED
A Study of Selexipag in Participants Who Participated in a Previous Selexipag Study
Actelion n=43
NCT03422328 COMPLETED
A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.
Actelion n=151
NCT03809884 COMPLETED
Dietary Counseling or Potassium Supplement to Increase Potassium Intake in Patients With High Blood Pressure
Ottawa Hospital Research Institute n=7
NCT06052748 COMPLETED
A Study to Evaluate the Efficacy and Safety of AD-223
Addpharma Inc. n=502
NCT04944290 COMPLETED
To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
Padagis LLC n=447
NCT02558231 COMPLETED
The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension
Actelion n=247
NCT05998837 COMPLETED
GLUcose Transport and REnalPROtection in Chronic Kidney Disease
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy n=34
NCT04927299 COMPLETED
Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension
Laboratorios Silanes S.A. de C.V. n=163
NCT02235909 COMPLETED
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
Arbor Pharmaceuticals, Inc. n=377
NCT03726398 WITHDRAWN
CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH
Franz Rischard, DO
NCT06438172 COMPLETED
A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension
Hanmi Pharmaceutical Company Limited n=249
NCT05838846 COMPLETED
Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery
Menoufia University n=60
NCT03001414 TERMINATED
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension
Northern Therapeutics n=22
NCT05878561 COMPLETED
A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy
Boryung Pharmaceutical Co., Ltd n=248
NCT04752475 COMPLETED
Lasix for the Prevention of De Novo Postpartum Hypertension
Columbia University n=82
NCT06728514 COMPLETED
Comparative Study of USG Guided ESPB vs USG Guided PVB For Post-op Analgesia In Patient's After Open Renal Surgeries
Sahiwal medical college sahiwal n=72
NCT04668157 COMPLETED
A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure
Takeda n=10
NCT03519386 COMPLETED
Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
Glaukos Corporation n=590
NCT03868124 COMPLETED
Clinical Study Comparing Two Models of a Travoprost Intraocular Implant
Glaukos Corporation n=560
NCT02620163 COMPLETED
Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment
Yuhan Corporation n=381
NCT05930028 COMPLETED
A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
Boryung Pharmaceutical Co., Ltd n=148
NCT05557942 TERMINATED
Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)
Aerovate Therapeutics n=186
NCT04576988 COMPLETED
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA n=324
NCT05227833 COMPLETED
Vonoprazan Efficacy to Prevent Post Variceal Band Ligation Ulcer
Alexandria University n=284
NCT05036135 TERMINATED
A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)
Aerovate Therapeutics n=202
NCT03399604 COMPLETED
Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil
Liquidia Technologies, Inc. n=121
NCT05820880 COMPLETED
Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension
Institut de Recherches Internationales Servier n=532
NCT05397600 COMPLETED
Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients
Laboratoires Thea n=684
NCT06500689 COMPLETED
To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil
Shenzhen Salubris Pharmaceuticals Co., Ltd. n=366
NCT02801617 TERMINATED
Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension
Laboratorios Sophia S.A de C.V. n=116
NCT06465264 COMPLETED
To Assess Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine or Allisartan Isoproxil
Shenzhen Salubris Pharmaceuticals Co., Ltd. n=499
NCT03689244 TERMINATED
A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment
Actelion n=128
NCT06448962 COMPLETED
Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022
Addpharma Inc. n=109
NCT05931224 COMPLETED
Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy
Chong Kun Dang Pharmaceutical n=346
NCT02757872 COMPLETED
Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
Albert Einstein College of Medicine n=2,232
NCT04133311 COMPLETED
A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension
Santen SAS n=386
NCT02185417 COMPLETED
Diuretic Comparison Project
VA Office of Research and Development n=20,723
NCT06413082 COMPLETED
Pharmacogenetics of Torasemide and Spironolactone in Hypertension Treatment
Ospedale San Raffaele n=38
NCT06416735 COMPLETED
Natriuretic Effect of Amiloride in Relation to the Alpha Adducin Gene (ADD-AMI) RS4961 Variant
Ospedale San Raffaele n=40
NCT02507687 COMPLETED
Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension
AbbVie n=240
NCT03961360 COMPLETED
Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida
The University of Texas Health Science Center, Houston n=220
NCT05359068 COMPLETED
Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension
Shanghai Pharmaceuticals Holding Co., Ltd n=957
NCT05347147 TERMINATED
A Trial to Determine the Efficacy and Safety of Presendin in IIH
Invex Therapeutics Ltd. n=14
NCT04615624 COMPLETED
Furosemide vs. Placebo for Severe Antepartum Hypertension
Melanie Maykin, MD n=65
NCT06121518 COMPLETED
Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy
Chong Kun Dang Pharmaceutical n=235
NCT05331014 COMPLETED
To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension
JW Pharmaceutical n=155
NCT05450601 COMPLETED
A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients
Hanmi Pharmaceutical Company Limited n=249
NCT03235232 COMPLETED
BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension
EMS n=406
NCT05022004 COMPLETED
A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Sun Pharmaceutical Industries Limited n=599
NCT03496623 TERMINATED
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
United Therapeutics n=188
NCT03825380 COMPLETED
Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients
Laboratoires Thea n=485
NCT04084678 TERMINATED
A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH
United Therapeutics n=10
NCT04591808 TERMINATED
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
Institut de Recherches Internationales Servier n=146
NCT05362110 COMPLETED
A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension
Hanmi Pharmaceutical Company Limited n=361
NCT04830449 COMPLETED
Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
Hanmi Pharmaceutical Company Limited n=122
NCT04820907 COMPLETED
Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
Hanmi Pharmaceutical Company Limited n=123
NCT05199129 COMPLETED
Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients
Hanmi Pharmaceutical Company Limited n=166
NCT04488874 COMPLETED
Sodium Lactate and Brain Relaxation (LSD)
Centre Hospitalier Universitaire de Besancon n=50
NCT04970108 WITHDRAWN
Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension
EMS
NCT05144360 WITHDRAWN
Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension
EMS
NCT03691649 COMPLETED
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study
Santen Inc. n=426
NCT03697811 COMPLETED
DE-117 Spectrum 5 Study
Santen Inc. n=107
NCT05476354 COMPLETED
Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients
Handok Inc. n=271
NCT05475665 COMPLETED
Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients
Handok Inc. n=157
NCT03691662 COMPLETED
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
Santen Inc. n=417
NCT03267108 TERMINATED
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension
Bellerophon Pulse Technologies n=145
NCT04898387 COMPLETED
Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.
Laboratoires Thea n=554
NCT03822559 COMPLETED
A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension
Santen Pharmaceutical Co., Ltd. n=219
NCT04285580 COMPLETED
A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension
AbbVie n=37
NCT03997097 WITHDRAWN
Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease
University Hospital, Montpellier
NCT02617459 COMPLETED
Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. n=366
NCT03541174 COMPLETED
A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety
Idorsia Pharmaceuticals Ltd. n=730
NCT05195827 WITHDRAWN
Effect of PRM-125 on Ambulatory Blood Pressure
PRM Pharma, LLC
NCT04024072 COMPLETED
To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
Padagis LLC n=495
NCT04620135 COMPLETED
Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Aerie Pharmaceuticals n=245
NCT03602781 WITHDRAWN
Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric
Bellerophon Pulse Technologies
NCT02725372 TERMINATED
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
Bellerophon Pulse Technologies n=207
NCT04857840 TERMINATED
Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH)
Quantum Genomics SA n=419
NCT02633293 TERMINATED
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
United Therapeutics n=243
NCT04162366 WITHDRAWN
A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
Idorsia Pharmaceuticals Ltd.
NCT04277884 COMPLETED
Firibastat in Treatment-resistant Hypertension
Quantum Genomics SA n=515
NCT02802254 COMPLETED
Increasing Risk Perception of Physical Activity Using Patient-targeted Feedback.
Universitätsklinikum Hamburg-Eppendorf n=121
NCT03504124 COMPLETED
Multicomponent Intervention to Improve Hypertension Control in Central America
Institute of Nutrition of Central America and Panama n=1,854
NCT02630316 COMPLETED
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
United Therapeutics n=326
NCT01620788 SUSPENDED
Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment
EMS n=636
NCT03814109 WITHDRAWN
Efficacy and Safety of Leningrado Association in the Treatment of Hypertension
EMS
NCT05437224 COMPLETED
Efficacy and Safety Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension
RenJi Hospital n=80
NCT03501966 TERMINATED
Surgical Idiopathic Intracranial Hypertension Treatment Trial
Jaeb Center for Health Research n=7
NCT04005079 WITHDRAWN
Pilocarpine After Combined Cataract/Trabectome Surgery
Montefiore Medical Center
NCT02636946 COMPLETED
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Allergan n=144
NCT03450629 COMPLETED
Evaluation of Safety and Efficacy of PDP-716
Sun Pharma Advanced Research Company Limited n=682
NCT02913664 COMPLETED
Risk Reduction for Alzheimer's Disease
University of Texas Southwestern Medical Center n=513
NCT03284853 COMPLETED
Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension
Aerie Pharmaceuticals n=436
NCT03009487 COMPLETED
A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia
Daewoong Pharmaceutical Co. LTD. n=265
NCT02918305 COMPLETED
Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension
JIMRO Co., Ltd. n=140
NCT03927443 WITHDRAWN
A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension
Sun Pharmaceutical Industries Limited
NCT04121299 WITHDRAWN
Mechanism of Masked Hypertension - Intervention
University of Alabama at Birmingham
NCT02914509 COMPLETED
Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT
Ocular Therapeutix, Inc. n=565
NCT04753112 COMPLETED
Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device
Germans Trias i Pujol Hospital n=14
NCT03514641 COMPLETED
An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension
Theracos n=673
NCT03991442 COMPLETED
BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination
Boryung Pharmaceutical Co., Ltd n=257
NCT03809650 TERMINATED
A Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Actelion n=9
NCT04158076 COMPLETED
Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine
Addpharma Inc. n=131
NCT03026426 COMPLETED
Effectiveness of a mHealth Intervention for the Treatment of Depression in People With Diabetes or Hypertension in Peru
Universidad Peruana Cayetano Heredia n=432
NCT03785067 TERMINATED
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study
The George Institute n=1
NCT03814148 WITHDRAWN
Efficacy and Safety of Leningrado 5 Association in the Treatment of Hypertension
EMS
NCT02662894 WITHDRAWN
Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.
EMS
NCT03872232 COMPLETED
Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan
Addpharma Inc. n=180
NCT02755298 COMPLETED
Chronic Clinical Effect of Acetazolamide
University of Zurich n=24
NCT04074551 COMPLETED
A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
Hanmi Pharmaceutical Company Limited n=145
NCT03037580 TERMINATED
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
United Therapeutics n=84
NCT02865733 COMPLETED
Study of Remodulin® in Pediatric Pulmonary Hypertension With Single Ventricular Physiology After Fontan Surgery
Shanghai Jiao Tong University School of Medicine n=36
NCT03043651 TERMINATED
Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF
United Therapeutics n=48
NCT03657095 TERMINATED
A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension
Lung Biotechnology PBC n=112
NCT02651870 COMPLETED
Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Chong Kun Dang Pharmaceutical n=135
NCT02558023 TERMINATED
The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
University Hospital, Strasbourg, France n=14
NCT03371173 TERMINATED
ORal IrON Supplementation With Ferric Maltol in Patients With Pulmonary Hypertension (ORION-PH-1)
Hannover Medical School n=22
NCT03246555 COMPLETED
Fimasartan in the Senior Subjects
Boryung Pharmaceutical Co., Ltd n=241
NCT02791438 COMPLETED
A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With Hypertension
Takeda n=27
NCT02782052 WITHDRAWN
Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension
Assistance Publique - Hôpitaux de Paris
NCT03257813 COMPLETED
Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)
Laboratorios Sophia S.A de C.V. n=60
NCT03338426 COMPLETED
A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia
Boryung Pharmaceutical Co., Ltd n=133
NCT03816540 COMPLETED
Diaphragmatic Breathing and Heart Rate Variability Training for Improving Hypertension in Fragile X Associated Tremor/Ataxia
University of California, Davis n=20
NCT02979197 COMPLETED
Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives
Kitov Pharma Ltd n=105
NCT02722265 COMPLETED
Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension
Daiichi Sankyo Co., Ltd. n=368
NCT03273387 COMPLETED
The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension
Indonesia University n=26
NCT03419975 COMPLETED
A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients
Taejoon Pharmaceutical Co., Ltd. n=146
NCT02755259 COMPLETED
Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension
University of Zurich n=33
NCT02575092 COMPLETED
The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment
Fuling Central Hospital of Chongqing City n=4,000
NCT03398785 COMPLETED
Adrenal Artery Ablation Treats Primary Aldosteronism
Third Military Medical University n=66
NCT02435303 TERMINATED
Effect of Sildenafil for Sustained PAH After MV Surgery (SUPERIOR Trial)
Asan Medical Center n=2
NCT03156842 COMPLETED
Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia
Boryung Pharmaceutical Co., Ltd n=138
NCT02558400 COMPLETED
Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Aerie Pharmaceuticals n=718
NCT02674854 COMPLETED
Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
Aerie Pharmaceuticals n=750
NCT03909945 COMPLETED
Evaluation of an Antihypertensive Food Supplement Based on Aqueous Extract From Annona Muricata Sheets
Yaounde Central Hospital n=21
NCT02480764 COMPLETED
Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension
Takeda n=612
NCT03067688 COMPLETED
Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia
Yuhan Corporation n=202
NCT02890173 COMPLETED
Study of CS-3150 in Patients With Essential Hypertension
Daiichi Sankyo Co., Ltd. n=1,001
NCT02808026 COMPLETED
Study of CS-3150 in Patients With Severe Hypertension
Daiichi Sankyo Co., Ltd. n=20
NCT02807974 COMPLETED
Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria
Daiichi Sankyo Co., Ltd. n=51
NCT02846662 COMPLETED
Effectiveness of a Mobile Technology Intervention for the Treatment of Depression
University of Sao Paulo General Hospital n=880
NCT02609490 COMPLETED
Azilsartan in Chinese Patients With Mild and Moderate Hypertension
Lee's Pharmaceutical Limited n=304
NCT02066649 WITHDRAWN
Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding
Rutgers, The State University of New Jersey
NCT02339584 COMPLETED
Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
Alcon Research n=493
NCT02558374 COMPLETED
Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
Aerie Pharmaceuticals n=708
NCT03210532 COMPLETED
Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia
Daewon Pharmaceutical Co., Ltd. n=129
NCT02471183 COMPLETED
Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension
Actelion n=34
NCT02623738 COMPLETED
A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-
Santen Pharmaceutical Co., Ltd. n=253
NCT02999906 WITHDRAWN
Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension
United Therapeutics
NCT02969265 WITHDRAWN
An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension
Takeda
NCT02955368 WITHDRAWN
Clinical Trial to Evaluate the Efficacy and Safety of DP-R212
Alvogen Korea
NCT02047019 WITHDRAWN
Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil
Bayer
NCT03055234 WITHDRAWN
Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease (SCD)
United Therapeutics
NCT02572219 COMPLETED
Effects of a Nutraceutical Preparation on Cognitive Impairment in Hypertensive Patients
Neuromed IRCCS n=12
NCT02521246 WITHDRAWN
Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control
EMS
NCT02521233 WITHDRAWN
Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control
EMS
NCT00293735 WITHDRAWN
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial
Baylor College of Medicine
NCT02770261 COMPLETED
Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy
Alvogen Korea n=219
NCT02565173 COMPLETED
Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma
Inotek Pharmaceuticals Corporation n=303
NCT02738632 COMPLETED
Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients
IlDong Pharmaceutical Co Ltd n=300
NCT02432937 COMPLETED
Corever in the Treatment of Hypertension
TSH Biopharm Corporation Limited n=134
NCT02916602 COMPLETED
A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605
Hanmi Pharmaceutical Company Limited n=340
NCT02586311 COMPLETED
CKD-330 Phase 3 Trial in Amlodipine Non-responder
Chong Kun Dang Pharmaceutical n=160
NCT02451150 COMPLETED
A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With Hypertension
Takeda n=6
NCT02436512 WITHDRAWN
Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide
Geno LLC